ENDOCYTE INC — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/44ad6318-fa80-4d79-95f7-76cbf603b7f4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $70.0k | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001164 |
| FY 2016 | $70.0k | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001674 |
| FY 2015 | $70.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-086648 |
| FY 2014 | $70.4M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-015921 |
| FY 2013 | $64.9M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-013535 |
| FY 2012 | $34.7M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-015715 |
| FY 2011 | $191.0k | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-136853 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-015715 |
| FY 2009 | $3.0M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-136853 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).